Publication:
Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions

Placeholder

Organizational Units

Program

Authors

Ince, ALİ TÜZÜN
YILDIZ, Kemal
BAYSAL, Birol
DANALIOGLU, Ahmet
KOCAMAN, Orhan
TOZLU, Mukaddes
GANGARAPU, Venkatanarayana
Kemik, Ahu Sarbay
Uysal, Omer
Senturk, HAKAN

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Background/Aims: Despite the presence of many diagnostic methods, the differential diagnosis between benign and malignant biliary obstructions is still not easy. We aimed to evaluate the role of serum/biliary carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA 19-9), vascular endothelial growth factor receptor-3(VEGFR-3), and total antioxidant capacity (TAC) tests in this differential diagnosis.

Description

Source:

Keywords:

Keywords

Citation

Ince A. T. , YILDIZ K., BAYSAL B., DANALIOGLU A., KOCAMAN O., TOZLU M., GANGARAPU V., Kemik A. S. , Uysal O., Senturk H., -Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions-, TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.25, ss.162-169, 2014

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals